Mndl
1 known investors
MNDL Bio uses AI-driven, host-optimized DNA sequence engineering to design recombinant protein expression constructs that increase yield and genetic stability while preserving the original amino-acid sequence. It serves bioproduction and biotechnology teams working across major expression systems, replacing trial-and-error experimentation with predictive in-silico design.